Estradiol/DRSP (Angeliq, BAY86-4891)

DRUG2 trials

Sponsors

Bayer

Conditions

PostmenopauseVasomotor Symptoms

Phase 3

Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.

CompletedNCT00356447

BayerVasomotor Symptoms

Start: 2006-05-31End: 2007-10-31Updated: 2014-10-01

Phase 4

Efficacy and Tolerability of Angeliq in Thai Women

CompletedNCT00185328

BayerPostmenopause

Start: 2005-09-30End: 2006-12-31Updated: 2008-12-12